{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:18:46Z","timestamp":1792880326712,"version":"4.5.0"},"reference-count":36,"publisher":"Medknow","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Basic Clin Pharma"],"published-print":{"date-parts":[[2014]]},"DOI":"10.4103\/0976-0105.139731","type":"journal-article","created":{"date-parts":[[2014,8,28]],"date-time":"2014-08-28T08:23:34Z","timestamp":1409214214000},"page":"79","source":"Crossref","is-referenced-by-count":58,"title":["Prescribing pattern and efficacy of anti-diabetic drugs in maintaining optimal glycemic levels in diabetic patients"],"prefix":"10.4103","volume":"5","author":[{"given":"AkshayA","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PradeepR","family":"Jadhav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YeshwantA","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2581","reference":[{"key":"key-10.4103\/0976-0105.139731-1","first-page":"3022","volume-title":"Prevalence of diabetes and prediabetes (impaired fasting glucose and\/or impaired glucose tolerance) in urban and rural India: Phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study","author":"Anjana","year":"2011","journal-title":"Diabetologia"},{"key":"key-10.4103\/0976-0105.139731-2","unstructured":"International Diabetes Federation. IDF Diabetes Atlas. 5 th ed. Brussels, Belgium: International Diabetes Federation; 2011. [Last accessed on 2012 Jul 10]. Available from: http:\/\/www.idf.org\/diabetesatlas."},{"key":"key-10.4103\/0976-0105.139731-3","first-page":"18","volume-title":"Current scenario of diabetes in India","author":"Ramachandran","year":"2009","journal-title":"J Diabetes"},{"key":"key-10.4103\/0976-0105.139731-4","unstructured":"Davis SN. Insulin, oral hypoglycemic agents, and pharmacology of the endocrine pancreas. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman and Gilman`s The Pharmacological Basis of Therapeutics. 11 th ed. United States of America McGraw-Hill; 2006. p. 1613-45."},{"key":"key-10.4103\/0976-0105.139731-5","unstructured":"Powers AC. Diabetes mellitus. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Lango DL, Jameson JL, editors. Harrison`s Principles of Internal Medicine. 16 th ed. New york McGraw-Hill; 2005. p. 2152-80."},{"key":"key-10.4103\/0976-0105.139731-6","first-page":"854","volume-title":"UK Prospective Diabetes Study (UKPDS) Group","author":"Effect","year":"1998","journal-title":"Lancet"},{"key":"key-10.4103\/0976-0105.139731-7","first-page":"837","volume-title":"UK Prospective Diabetes Study (UKPDS) Group","author":"Intensive","year":"1998","journal-title":"Lancet"},{"key":"key-10.4103\/0976-0105.139731-8","first-page":"807","volume-title":"Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management","author":"Grant","year":"2007","journal-title":"Diabetes Care"},{"key":"key-10.4103\/0976-0105.139731-9","first-page":"1447","volume-title":"Sustained hyperglycemia among patients with diabetes: What matters when action is needed?","author":"Lafata","year":"2009","journal-title":"Diabetes Care"},{"key":"key-10.4103\/0976-0105.139731-10","first-page":"1339","volume-title":"Weight change and glycemic control after diagnosis of type 2 diabetes","author":"Feldstein","year":"2008","journal-title":"J Gen Intern Med"},{"key":"key-10.4103\/0976-0105.139731-11","first-page":"677","volume-title":"Inadequate glycaemic control and antidiabetic therapy among inpatients with type 2 diabetes in Guangdong Province of China","author":"Bi","year":"2008","journal-title":"Chin Med J (Engl)"},{"key":"key-10.4103\/0976-0105.139731-12","first-page":"b1668","volume-title":"Newer agents for blood glucose control in type 2 diabetes: Summary of NICE guidance","author":"Adler","year":"2009","journal-title":"BMJ"},{"key":"key-10.4103\/0976-0105.139731-13","first-page":"598","volume-title":"Glycemic response to newly initiated diabetes therapies","author":"Karter","year":"2007","journal-title":"Am J Manag Care"},{"key":"key-10.4103\/0976-0105.139731-14","first-page":"316","volume-title":"Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: A retrospective database study","author":"Yurgin","year":"2007","journal-title":"Clin Ther"},{"key":"key-10.4103\/0976-0105.139731-15","first-page":"137","volume-title":"Prevalence and correlates of inadequate glycaemic control: Results from a nationwide survey in 6,671 adults with diabetes in Brazil","author":"Mendes","year":"2010","journal-title":"Acta Diabetol"},{"key":"key-10.4103\/0976-0105.139731-16","first-page":"717","volume-title":"DiabCare Asia - India Study: Diabetes care in India - current status","author":"Raheja","year":"2001","journal-title":"J Assoc Physicians India"},{"key":"key-10.4103\/0976-0105.139731-17","first-page":"2341","volume-title":"Quality of diabetes care in the middle- and high-income group populace: The Delhi Diabetes Community (DEDICOM) survey","author":"Nagpal","year":"2006","journal-title":"Diabetes Care"},{"key":"key-10.4103\/0976-0105.139731-18","unstructured":"World Health Organization (WHO) and International Network for Rational Use of Drugs. How to Investigate Drug Use in Health Facilities: Selected Drug Use indicators. Geneva, Switzerland: WHO; 1993. (WHO\/DAP\/93.1)."},{"key":"key-10.4103\/0976-0105.139731-19","unstructured":"National List of Essential Medicines of India 2011. Ministry of Health and Family Welfare, Government of India. Available from: http:\/\/www.pharmaceuticals.gov.in\/NLEM.pdf. [Last cited on 2012 Jan 10]."},{"key":"key-10.4103\/0976-0105.139731-20","unstructured":"WHO Essential Medicine List 2011. World Health Organization. Available from: http:\/\/www.whqlibdoc.who.int\/hq\/2011\/a95053_eng.pdf. [Last cited on 2012 Jan 10]."},{"key":"key-10.4103\/0976-0105.139731-21","first-page":"27","volume-title":"Outpatient utilization of anti-diabetic drugs in the South Eastern Nigeria","author":"Adibe","year":"2009","journal-title":"Int J Drug Dev Res"},{"key":"key-10.4103\/0976-0105.139731-22","first-page":"1","volume-title":"Prescription pattern study in type 2 diabetes mellitus in an Indian referral hospital","author":"Hasamnis","year":"2009","journal-title":"Internet J Pharmacol"},{"key":"key-10.4103\/0976-0105.139731-23","first-page":"440","volume-title":"Drug utilisation study in geriatric type 2 diabetic patients","author":"Rajeshwari","year":"2007","journal-title":"J Clin Diagn Res"},{"key":"key-10.4103\/0976-0105.139731-24","first-page":"237","volume-title":"Drug utilization study in diabetology outpatient setting of a tertiary hospital","author":"Sutharson","year":"2003","journal-title":"Indian J Pharmacol","ISSN":"https:\/\/id.crossref.org\/issn\/0253-7613","issn-type":"print"},{"key":"key-10.4103\/0976-0105.139731-25","first-page":"141","volume-title":"Prescription pattern of antidiabetic drugs in the outpatient departments of hospitals in Malappuram district, Kerala","author":"Shamna","year":"2011","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"key-10.4103\/0976-0105.139731-26","first-page":"485","volume-title":"Pattern of antidiabetic drugs use in type-2 diabetic patients in a medicine outpatient clinic of a tertiary care teaching hospital","author":"Patel","year":"2013","journal-title":"Int J Basic Clin Pharmacol"},{"key":"key-10.4103\/0976-0105.139731-27","first-page":"417","volume-title":"An investigation into antidiabetic medication prescribing in South Africa","author":"Truter","year":"1998","journal-title":"J Clin Pharm Ther"},{"key":"key-10.4103\/0976-0105.139731-28","first-page":"267","volume-title":"Drug utilization of oral hypoglycemic agents in a university teaching hospital in India","author":"Sultana","year":"2010","journal-title":"J Clin Pharm Ther"},{"key":"key-10.4103\/0976-0105.139731-29","first-page":"40","volume-title":"Trend in the use of oral hypoglycemic agents in an outpatient pharmacy department of a tertiary hospital in Malaysia (2003-2006)","author":"Hassan","year":"2009","journal-title":"Asian J Pharm Clin Res"},{"key":"key-10.4103\/0976-0105.139731-30","first-page":"325","volume-title":"Baseline characteristics of the Indian cohort from the IMPROVE study: A multinational, observational study of biphasic insulin aspart 30 treatment for type 2 diabetes","author":"Shah","year":"2009","journal-title":"Adv Ther"},{"key":"key-10.4103\/0976-0105.139731-31","first-page":"485","volume-title":"Pattern of antidiabetic drugs use in type-2 diabetic patients in a medicine outpatient clinic of a tertiary care teaching hospital","author":"Patel","year":"2013","journal-title":"Int J Basic Clin Pharmacol"},{"key":"key-10.4103\/0976-0105.139731-32","first-page":"435","volume-title":"Polypharmacy with oral antidiabetic agents: An indicator of poor glycemic control","author":"Willey","year":"2006","journal-title":"Am J Manag Care"},{"key":"key-10.4103\/0976-0105.139731-33","first-page":"443","volume-title":"Predictive factors of glycemic control in patients with type 2 diabetes mellitus in primary health care","author":"Ben","year":"2006","journal-title":"Rev Epidemiol Sante Publique"},{"key":"key-10.4103\/0976-0105.139731-34","first-page":"407","volume-title":"Glycemic control and its correlates in patients with diabetes in Venezuela: Results from a nationwide survey","author":"Moreira","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"key-10.4103\/0976-0105.139731-35","first-page":"281","volume-title":"Pharmacologic therapy for type 2 diabetes mellitus","author":"DeFronzo","year":"1999","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/0976-0105.139731-36","first-page":"688","volume-title":"Comparison of glucometers used in hospitals and in outpatient settings with the laboratory reference method in a tertiary care hospital in Mumbai","author":"Ullal","year":"2013","journal-title":"Indian J Endocr Metab","ISSN":"https:\/\/id.crossref.org\/issn\/2230-8210","issn-type":"print"}],"container-title":["Journal of Basic and Clinical Pharmacy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2014,9,2]],"date-time":"2014-09-02T13:00:17Z","timestamp":1409662817000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jbclinpharm.org\/text.asp?2014\/5\/3\/79\/139731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"alternative-id":["139731"],"URL":"https:\/\/doi.org\/10.4103\/0976-0105.139731","relation":{},"ISSN":["0976-0105"],"issn-type":[{"value":"0976-0105","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}